Sanger spin­out gets $10M, tack­les the mi­cro­bio­me fron­tier; Adap­ti­m­mune and Bel­licum part­ner T cell tech

The Sanger In­sti­tute has launched a new spin­out dubbed Mi­cro­bi­ot­i­ca, which is leap­ing in­to the hot mi­cro­bio­me field. The IP Group and Cam­bridge In­no­va­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.